Ocular Therapeutix, Inc.

OCUL·NasdaqGM·Healthcare
Compare
7.14+0.32 (+4.69%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close6.82
Open7.09
Day range6.837.17
52-week range6.0016.44
Off day high−0.35%
Off 52-week high−56.57%
Volume3.36M
Avg. volume (3M)3.04M
Market cap1.57B
EPS (TTM)-1.40
Forward P/E-4.82
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.22
Shares outstanding219.62M
Short interest15.46% of float
Earnings dateNov 9, 2026
Analyst target25.45
Profit margin0.00%

Against its peers

Compare in full ›
OCUL YDES 1477.HK 4576.T TARS MGTX
Market cap 1.57B 492.28M 4.05B 3.11B 3.23B 904.72M
P/E (TTM) — — — — — 10.8
Forward P/E -4.8 — 17.3 — -138.1 -6.2
Price/book 3.0 110.3 1.0 2.2 32.7 4.1
Dividend yield — — — — — —
1-year change −36.91% −39.33% −40.60% −47.12% +6.51% +10.96%
Today +4.69% +7.84% +0.30% −1.82% −4.91% −1.05%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Ocular Therapeutix's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
YD Bio LtdYDES · Biotechnology 492.28M 6.95 +7.84%
Ocumension Therapeutics1477.HK · Biotechnology 4.05B 5.070 +0.30%
D. Western Therapeutics Institute, Inc.4576.T · Biotechnology 3.11B 54.00 −1.82%
Tarsus Pharmaceuticals, Inc.TARS · Biotechnology 3.23B 69.07 −4.91%
MeiraGTx Holdings plcMGTX · Biotechnology 904.72M 9.42 −1.05%
EyePoint, Inc.EYPT · Biotechnology 33.12M 0.3950 −1.23%
Kodiak Sciences Inc.KOD · Biotechnology 6.19B 98.51 −0.38%
Surrozen, Inc.SRZN · Biotechnology 553.72M 31.65 +5.08%

Also based in Bedford, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Lantheus Holdings, Inc.LNTH · Bedford, MA 6.60B 101.14 +0.34%
Novanta Inc.NOVT · Bedford, MA 5.49B 145.23 −1.53%
Stoke Therapeutics, Inc.STOK · Bedford, MA 1.78B 27.45 +1.70%
Anika Therapeutics, Inc.ANIK · Bedford, MA 273.01M 20.40 +4.88%
The TJX Companies, Inc.TJX · Framingham, MA 159.23B 144.76 +5.18%
Vertex Pharmaceuticals IncorporatedVRTX · Boston, MA 139.16B 549.04 +3.44%
Moderna, Inc.MRNA · Cambridge, MAOdds 103.15B 258.38 +13.11%
American Tower CorporationAMT · Boston, MA 90.37B 194.86 +4.04%

The stocks whose daily moves over the past year went most closely with Ocular Therapeutix's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
EyePoint, Inc.EYPT · Correlation 0.38 33.12M 0.3950 −1.23%
Structure Therapeutics Inc.GPCR · Correlation 0.36 1.45B 20.36 +0.05%

What visitors to Ocular Therapeutix's page also look at.

Company Mkt cap Price Today
Karyopharm Therapeutics Inc.KPTI 1.65M 0.0729 −17.44%
Omeros CorporationOMER 1.32B 18.18 −0.49%
EyePoint, Inc.EYPT 33.12M 0.3950 −1.23%
PTC Therapeutics, Inc.PTCT 5.76B 68.97 +1.25%
Aurinia Pharmaceuticals IncAUPH 2.29B 17.11 +3.32%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All OCUL news ›
The Globe and Mail·Negative

Kits Eyecare CEO buys the dip

Roger Hardy adds to stake We have our eye on Kits Eyecare Ltd. (KITS-T), which has pulled back from its 52-week high of $22.56 set on Jan. 15. Last Friday, CEO Roger Hardy spent $774,950 picking up shares in the public market after the…

OCULCOO
Stock Titan·

Ocugen CEO Shankar Musunuri sells 468,727 shares

Ocugen, Inc. (NASDAQ: OCGN) is a biotechnology company developing modifier gene therapies for major blindness diseases, including RP, Stargardt disease, and GA. Ocugen CEO Shankar Musunuri sells 468,727 shares Both sale entries were…

OCULOCGNUTHRORKA
Stock Titan·

Ocular Therapeutix: Anderman sells 11,984 shares

To cover vesting taxes, Ocular Therapeutix (OCUL) legal chief sold 11,984 shares. Stock Titan - [Form 4] OCULAR THERAPEUTIX, INC Insider Trading Activity Ocular Therapeutix: Anderman sells 11,984 shares The chief legal officer's shares…

OCULORKAKIDS

From the 4Search news index, newest first.

In the news

19mentions in 30 days
11with it in the headline
Positivesentiment

Mentioned with

Ocular Therapeutix, Inc.15Dextenza14Corporation13Morgan Stanley Smith Barney Llc6Ptc Therapeutics6Ptc Therapeutics, Inc.6American Academy of Ophthalmology4Eli Lilly4

People in the coverage

Jeffrey S. Heier15Donald Notman6Peter Kazuo Kaiser5Arjun Agarwal4Brent Saunders4Todd Anderman4

Themes

Biotechnology15Healthcare15SEC Filings14Form 411Insider Sale9Common Stock8Tax Withholding8Form 1447

Most coverage from

  1. stocktitan.net9
  2. themarketsdaily.com3
  3. seekingalpha.com2
  4. gurufocus.com1
  5. manilatimes.net1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 19 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance